| Income Statement |
| Total Revenue | 1.42M |
|
| Revenues (USD) | 1.42M |
| Cost of Revenue | 192.00K |
| Gross Profit | 1.22M |
| Operating Expenses | 13.05M |
| Research and Development Expense | 5.51M |
| Selling, General and Administrative Expense | 7.54M |
| Operating Income | -11.82M |
| Net Income | -10.77M |
| Net Income Common Stock | -10.77M |
| Net Income Common Stock (USD) | -10.77M |
| Consolidated Income | -10.77M |
| Earnings per Basic Share | -3.10 |
| Earnings per Basic Share (USD) | -3.10 |
| Earnings per Diluted Share | -3.10 |
| Earning Before Interest & Taxes (EBIT) | -10.77M |
| Earning Before Interest & Taxes (USD) | -10.77M |
| Weighted Average Shares | 3.47M |
| Weighted Average Shares Diluted | 3.47M |
| Balance Sheet |
| Cash and Equivalents | 3.32M |
| Cash and Equivalents (USD) | 3.32M |
| Trade and Non-Trade Receivables | 216.00K |
| Current Assets | 3.77M |
| Property, Plant & Equipment Net | 630.00K |
| Total Assets | 4.53M |
| Debt Current | 2.63M |
| Total Debt | 2.80M |
| Current Liabilities | 16.36M |
| Debt Non-Current | 169.00K |
| Total Liabilities | 16.58M |
| Accumulated Retained Earnings (Deficit) | -58.14M |
| Shareholders Equity | -12.05M |
| Shareholders Equity (USD) | -12.05M |
| Assets Non-Current | 755.00K |
| Total Debt (USD) | 2.80M |
| Deferred Revenue | 2.33M |
| Liabilities Non-Current | 210.00K |
| Trade and Non-Trade Payables | 2.48M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 14.00K |
| Net Cash Flow from Financing | 5.62M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.02M |
| Capital Expenditure | -5.00K |
| Issuance (Purchase) of Equity Shares | 8.00M |
| Issuance (Repayment) of Debt Securities | -3.71M |
| Net Cash Flow from Investing | -5.00K |
| Net Cash Flow from Operations | -2.60M |
| Effect of Exchange Rate Changes on Cash | -22.00K |
| Share Based Compensation | 4.21M |